News
October 03, 2025
PharmaCorp Closes Acquisitions of Three Pharmacies Across Canada
SASKATOON, Saskatchewan, Oct. 02, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that it has completed the acquisitions of three community pharmacy businesses, two located in Western Canada and one located in Eastern Canada (collectively, the “Acquisitions”). Western Canada Acquisitions PharmaCorp has closed its previously announced [...]
PharmaCorp, a publicly traded pharmaceutical company (TSXV: PCRX), has significantly expanded its reach across Canada with the successful completion of three key acquisitions. The company announced today that it has finalized deals to acquire three community pharmacy businesses, strategically located to enhance its presence in both Western and Eastern Canada.
These acquisitions, collectively referred to as the "Acquisitions," represent a significant step in PharmaCorp's growth strategy, allowing the corporation to serve a wider range of communities and patients. Two of the acquired pharmacies are situated in Western Canada, bolstering PharmaCorp's existing network in the region. The third pharmacy, located in Eastern Canada, marks a strategic expansion into a new market, demonstrating the company's commitment to national coverage.
The announcement, released today, October 2nd, 2025, highlights PharmaCorp's dedication to providing accessible and comprehensive pharmaceutical services to Canadians. While specific details regarding the financial terms of the acquisitions were not immediately disclosed, the company emphasized the strategic importance of these additions to its portfolio.
By integrating these established community pharmacies into its existing framework, PharmaCorp expects to leverage synergies in operations, supply chain management, and patient care. This includes implementing best practices across all locations and ensuring a consistent standard of service for customers nationwide.
The move underscores PharmaCorp’s ambition to become a leading player in the Canadian pharmaceutical landscape. The acquisition of these established pharmacies provides PharmaCorp with an immediate foothold in these communities, along with existing patient relationships and established reputations. The company is poised to capitalize on these assets and further strengthen its brand recognition across the country. The successful completion of these acquisitions is expected to contribute positively to PharmaCorp's future growth and profitability, reinforcing its position as a trusted provider of pharmaceutical care.
These acquisitions, collectively referred to as the "Acquisitions," represent a significant step in PharmaCorp's growth strategy, allowing the corporation to serve a wider range of communities and patients. Two of the acquired pharmacies are situated in Western Canada, bolstering PharmaCorp's existing network in the region. The third pharmacy, located in Eastern Canada, marks a strategic expansion into a new market, demonstrating the company's commitment to national coverage.
The announcement, released today, October 2nd, 2025, highlights PharmaCorp's dedication to providing accessible and comprehensive pharmaceutical services to Canadians. While specific details regarding the financial terms of the acquisitions were not immediately disclosed, the company emphasized the strategic importance of these additions to its portfolio.
By integrating these established community pharmacies into its existing framework, PharmaCorp expects to leverage synergies in operations, supply chain management, and patient care. This includes implementing best practices across all locations and ensuring a consistent standard of service for customers nationwide.
The move underscores PharmaCorp’s ambition to become a leading player in the Canadian pharmaceutical landscape. The acquisition of these established pharmacies provides PharmaCorp with an immediate foothold in these communities, along with existing patient relationships and established reputations. The company is poised to capitalize on these assets and further strengthen its brand recognition across the country. The successful completion of these acquisitions is expected to contribute positively to PharmaCorp's future growth and profitability, reinforcing its position as a trusted provider of pharmaceutical care.
Category:
Business